Seer Past Earnings Performance
Past criteria checks 0/6
Seer's earnings have been declining at an average annual rate of -0.6%, while the Life Sciences industry saw earnings declining at 4.3% annually. Revenues have been growing at an average rate of 14.1% per year.
Key information
-0.62%
Earnings growth rate
0.78%
EPS growth rate
| Life Sciences Industry Growth | 21.51% |
| Revenue growth rate | 14.15% |
| Return on equity | -30.12% |
| Net Margin | -478.05% |
| Last Earnings Update | 30 Jun 2026 |
Recent past performance updates
Recent updates
This Seer Vote Could Decide Between Takeout Optionality And Standalone Path
Summary Seer, Inc. sits at a critical inflection point, trading at a negative enterprise value with a $166M cash balance versus a $119M market cap. Recent unsolicited $2.45/share take-private bid by CEO was rejected, highlighting a board focus on long-term optionality over near-term liquidity. 1Q26 results show declining revenue (-34% YoY), reasonable gross margin (35%), improved cost discipline, and a 3+ year cash runway despite ongoing cash burn. Active proxy battle and uncertain strategic direction keep SEER an event-driven, balanced risk/reward play pending evidence of commercial traction or strategic clarity. Read the full article on Seeking Alpha
SEER: Activist Bid And Buybacks Will Test Bullish Repricing Thesis
Analysts have raised their price target on Seer to $4.00, citing updated assumptions for higher revenue growth, a modestly higher discount rate, and a lower future P/E multiple as the key drivers of this revised view. What’s in the News for Seer Bradley L.SEER: Bullish Coverage And Activist Pressure Will Test Profitability Execution
Analysts have raised their price target on Seer to $4.00 from $4, citing updated expectations for revenue growth, profit margins and future P/E following fresh bullish research coverage. What's in the News On April 13, 2026, Bradley L.SEER: Raised Fair Value Will Rely On Improved Profitability Execution
Analysts have raised their price target on Seer from $3.29 to $4.00, citing recent bullish coverage that focuses on revised assumptions for growth, profitability, and future P/E multiples. Analyst Commentary Bullish Takeaways Bullish analysts view the higher price target as a reflection of revised assumptions on Seer’s long term growth potential, which they see as better aligning the stock’s valuation with its business opportunity.US$3.00: That's What Analysts Think Seer, Inc. (NASDAQ:SEER) Is Worth After Its Latest Results
Seer, Inc. ( NASDAQ:SEER ) investors will be delighted, with the company turning in some strong numbers with its latest...
Proteograph Product Suite And Thermo Fisher Partnership Will Open Markets
Strategic investments in commercial infrastructure and leadership aim to support revenue growth through increased productivity and sales effectiveness.We're Keeping An Eye On Seer's (NASDAQ:SEER) Cash Burn Rate
Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...Seer, Inc. (NASDAQ:SEER) Just Reported, And Analysts Assigned A US$7.00 Price Target
Shareholders of Seer, Inc. ( NASDAQ:SEER ) will be pleased this week, given that the stock price is up 18% to US$1.82...Newsflash: Seer, Inc. (NASDAQ:SEER) Analysts Have Been Trimming Their Revenue Forecasts
Today is shaping up negative for Seer, Inc. ( NASDAQ:SEER ) shareholders, with the analysts delivering a substantial...Revenue & Expenses Breakdown
How Seer makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 26 | 14 | -68 | 40 | 38 |
| 31 Mar 26 | 15 | -70 | 41 | 41 |
| 31 Dec 25 | 17 | -74 | 43 | 44 |
| 30 Sep 25 | 16 | -79 | 46 | 47 |
| 30 Jun 25 | 16 | -82 | 48 | 49 |
| 31 Mar 25 | 15 | -86 | 54 | 50 |
| 31 Dec 24 | 14 | -87 | 57 | 51 |
| 30 Sep 24 | 15 | -83 | 57 | 49 |
| 30 Jun 24 | 15 | -82 | 58 | 49 |
| 31 Mar 24 | 16 | -83 | 58 | 51 |
| 31 Dec 23 | 17 | -86 | 59 | 53 |
| 30 Sep 23 | 17 | -91 | 60 | 54 |
| 30 Jun 23 | 17 | -94 | 61 | 53 |
| 31 Mar 23 | 16 | -93 | 59 | 50 |
| 31 Dec 22 | 15 | -93 | 59 | 46 |
| 30 Sep 22 | 14 | -90 | 57 | 41 |
| 30 Jun 22 | 12 | -85 | 53 | 38 |
| 31 Mar 22 | 10 | -78 | 50 | 34 |
| 31 Dec 21 | 7 | -71 | 46 | 29 |
| 30 Sep 21 | 4 | -64 | 41 | 26 |
| 30 Jun 21 | 2 | -54 | 32 | 23 |
| 31 Mar 21 | 1 | -44 | 24 | 25 |
| 31 Dec 20 | 1 | -33 | 15 | 19 |
| 30 Sep 20 | 0 | -25 | 9 | 14 |
| 31 Dec 19 | 0 | -16 | 5 | 0 |
Quality Earnings: SEER is currently unprofitable.
Growing Profit Margin: SEER is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SEER is unprofitable, and losses have increased over the past 5 years at a rate of 0.6% per year.
Accelerating Growth: Unable to compare SEER's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: SEER is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (9.6%).
Return on Equity
High ROE: SEER has a negative Return on Equity (-30.12%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/09/15 02:13 |
| End of Day Share Price | 2026/09/14 00:00 |
| Earnings | 2026/06/30 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Seer, Inc. is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Derik de Bruin | BofA Global Research |
| Kyle Mikson | Canaccord Genuity |
| Daniel Brennan | TD Cowen |